Koninklijke Philips NV (PHG)
25.90
-0.47
(-1.78%)
USD |
NYSE |
Sep 03, 11:20
Koninklijke Philips Research and Development Expense (Annual) : 1.919B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.919B |
| December 31, 2024 | 1.890B |
| December 31, 2023 | 2.028B |
| December 31, 2022 | 1.996B |
| December 31, 2021 | 1.937B |
| December 31, 2020 | 1.807B |
| December 31, 2019 | 1.823B |
| December 31, 2018 | 1.722B |
| December 31, 2017 | 1.561B |
| December 31, 2016 | 1.574B |
| December 31, 2015 | 1.836B |
| December 31, 2014 | 1.862B |
| December 31, 2013 | 1.905B |
| December 31, 2012 | 2.000B |
| December 31, 2011 | 1.998B |
| December 31, 2010 | 1.976B |
| December 31, 2009 | 2.024B |
| December 31, 2008 | 2.611B |
| Date | Value |
|---|---|
| December 31, 2007 | 2.230B |
| December 31, 2006 | 2.035B |
| December 31, 2005 | 3.144B |
| December 31, 2004 | 3.104B |
| December 31, 2003 | 2.958B |
| December 31, 2002 | 2.869B |
| December 31, 2001 | 2.963B |
| December 31, 2000 | 2.547B |
| December 31, 1999 | 2.420B |
| December 31, 1998 | 2.277B |
| December 31, 1997 | 2.076B |
| December 31, 1996 | 2.398B |
| December 31, 1995 | 2.416B |
| December 31, 1994 | 2.060B |
| December 31, 1993 | 1.825B |
| December 31, 1992 | 2.089B |
| December 31, 1991 | 2.072B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ResMed, Inc. | 378.28M |
| Medtronic Plc | 2.873B |
| EDAP TMS SA | -- |
| iRhythm Holdings, Inc. | 84.61M |
| GE Healthcare Technologies, Inc. | 1.26B |